The requirement of Rac for NSCLC cell migration was establishedby means of expressing either the RacGTPase activating protein (Rac-GAP) β2-chimaerin [35] or a dominant-negative Rac mutant (N17-Rac1) using adenoviral means. This evidence concerns the gene RAC1 and non-small cell lung carcinoma.